Works matching IS 11707690 AND DT 2022 AND VI 40

Results: 119

Estimating an EQ-5D-Y-3L Value Set for Indonesia by Mapping the DCE onto TTO Values.

Published in:

PharmacoEconomics, 2022, v. 40, p. 157, doi. 10.1007/s40273-022-01210-1

By:

Fitriana, Titi Sahidah;
Roudijk, Bram;
Purba, Fredrick Dermawan;
Busschbach, Jan J. V.;
Stolk, Elly

Publication type:

Article

EQ-5D-Y-3L Value Sets, Valuation Methods and Conceptual Questions.

Published in:

PharmacoEconomics, 2022, v. 40, p. 123, doi. 10.1007/s40273-022-01226-7

By:

Devlin, Nancy;
Roudijk, Bram;
Viney, Rosalie;
Stolk, Elly

Publication type:

Article

Findings from a Roundtable Discussion with US Stakeholders on Valuation of the EQ-5D-Y-3L.

Published in:

2022

By:

Nazari, Jonathan L.;
Pickard, A. Simon;
Gu, Ning Yan

Publication type:

Proceeding

Estimating an EQ-5D-Y-3L Value Set for China.

Published in:

PharmacoEconomics, 2022, v. 40, p. 147, doi. 10.1007/s40273-022-01216-9

By:

Yang, Zhihao;
Jiang, Jie;
Wang, Pei;
Jin, Xuejing;
Wu, Jing;
Fang, Yu;
Feng, Da;
Xi, Xiaoyu;
Li, Shunping;
Jing, Mingxia;
Zheng, Bin;
Huang, Weidong;
Luo, Nan

Publication type:

Article

Analytical Considerations When Anchoring Discrete Choice Experiment Values Using Composite Time Trade-Off Data: The Case of EQ-5D-Y-3L.

Published in:

PharmacoEconomics, 2022, v. 40, p. 129, doi. 10.1007/s40273-022-01214-x

By:

Mott, David J.;
Devlin, Nancy J.;
Kreimeier, Simone;
Norman, Richard;
Shah, Koonal K.;
Rivero-Arias, Oliver

Publication type:

Article

Correction to: EQ-5D-Y Value Set for Germany.

Published in:

2022

By:

Kreimeier, Simone;
Mott, David;
Ludwig, Kristina;
Greiner, Wolfgang;
IMPACT HTA HRQoL Group;
Prevolnik Rupel, Valentina;
Ramos-Goñi, Juan Manuel

Publication type:

Correction Notice

PharmacoEconomics: Supplement.

Published in:: PharmacoEconomics, 2022, v. 40, p. 121, doi. 10.1007/s40273-022-01204-z
Publication type:: Article

In a Child's Shoes: Composite Time Trade-Off Valuations for EQ-5D-Y-3L with Different Proxy Perspectives.

Published in:

PharmacoEconomics, 2022, v. 40, p. 181, doi. 10.1007/s40273-022-01202-1

By:

Lipman, Stefan A.;
Essers, Brigitte A. B.;
Finch, Aureliano P.;
Sajjad, Ayesha;
Stalmeier, Peep F. M.;
Roudijk, Bram

Publication type:

Article

A Value Set for the EQ-5D-Y-3L in the Netherlands.

Published in:

PharmacoEconomics, 2022, v. 40, p. 193, doi. 10.1007/s40273-022-01192-0

By:

Roudijk, Bram;
Sajjad, Ayesha;
Essers, Brigitte;
Lipman, Stefan;
Stalmeier, Peep;
Finch, Aureliano Paolo

Publication type:

Article

Value Set for the EQ-5D-Y-3L in Hungary.

Published in:

PharmacoEconomics, 2022, v. 40, p. 205, doi. 10.1007/s40273-022-01190-2

By:

Rencz, Fanni;
Ruzsa, Gábor;
Bató, Alex;
Yang, Zhihao;
Finch, Aureliano Paolo;
Brodszky, Valentin

Publication type:

Article

Getting the Price Right: Lessons for Medicare Price Negotiation from Peer Countries.

Published in:

PharmacoEconomics, 2022, v. 40, n. 12, p. 1131, doi. 10.1007/s40273-022-01195-x

By:

Rand, Leah Z.;
Kesselheim, Aaron S.

Publication type:

Article

An EQ-5D-Y-3L Value Set for Belgium.

Published in:

PharmacoEconomics, 2022, v. 40, p. 169, doi. 10.1007/s40273-022-01187-x

By:

Dewilde, Sarah;
Roudijk, Bram;
Tollenaar, Nafthali H.;
Ramos-Goñi, Juan M.

Publication type:

Article

Response to Comment on "An Integrated Pharmacokinetic-Pharmacodynamic-Pharmacoeconomic Modeling Method to Evaluate Treatments for Adults with Schizophrenia".

Published in:

PharmacoEconomics, 2022, v. 40, n. 12, p. 1265, doi. 10.1007/s40273-022-01213-y

By:

Piena, Marjanne A.;
Houwing, Natalie;
Kraan, Carla W.;
Wang, Xiaofeng;
Waters, Heidi;
Bennison, Craig

Publication type:

Article

Economic Implications of Endometriosis: A Review.

Published in:

PharmacoEconomics, 2022, v. 40, n. 12, p. 1143, doi. 10.1007/s40273-022-01211-0

By:

Darbà, Josep;
Marsà, Alicia

Publication type:

Article

Cost Effectiveness of Adding Pembrolizumab to Platinum and Fluoropyrimidine-Based Chemotherapy as First-Line Treatment for Advanced Esophageal Cancer: A US Healthcare Payer's Perspective.

Published in:

PharmacoEconomics, 2022, v. 40, n. 12, p. 1247, doi. 10.1007/s40273-022-01196-w

By:

Qu, Tingting;
Zhang, Shujing;
Zhong, Yichen;
Meng, Yang;
Guo, He;
Joo, Seongjung;
Enzinger, Peter C.

Publication type:

Article

Cost-Effectiveness Analysis of Prostate Cancer Screening in the UK: A Decision Model Analysis Based on the CAP Trial.

Published in:

PharmacoEconomics, 2022, v. 40, n. 12, p. 1207, doi. 10.1007/s40273-022-01191-1

By:

Keeney, Edna;
Sanghera, Sabina;
Martin, Richard M.;
Gulati, Roman;
Wiklund, Fredrik;
Walsh, Eleanor I.;
Donovan, Jenny L.;
Hamdy, Freddie;
Neal, David E.;
Lane, J. Athene;
Turner, Emma L.;
Thom, Howard;
Clements, Mark S.

Publication type:

Article

EQ-5D-Y Value Set for Germany.

Published in:

PharmacoEconomics, 2022, v. 40, p. 217, doi. 10.1007/s40273-022-01143-9

By:

Kreimeier, Simone;
Mott, David;
Ludwig, Kristina;
Greiner, Wolfgang;
IMPACT HTA HRQoL Group;
Prevolnik Rupel, Valentina;
Ramos-Goñi, Juan Manuel

Publication type:

Article

Conceptual Framework for Optimised Proxy Value Set Selection Through Supra-National Value Set Development for the EQ-5D Instruments.

Published in:

PharmacoEconomics, 2022, v. 40, n. 12, p. 1221, doi. 10.1007/s40273-022-01194-y

By:

Łaszewska, Agata;
Sajjad, Ayesha;
Busschbach, Jan;
Simon, Judit;
Hakkaart-van Roijen, Leona

Publication type:

Article

Efficiency of the EmERGE Pathway of Care in Five European HIV Centres.

Published in:

2022

By:

Beck, Eduard J.;
Mandalia, Sundhiya;
Yfantopoulos, Platon;
Leon, Agathe;
Merino, Marie J.;
Garcia, Felipe;
Wittevogel, Marie;
Apers, Ludwig;
Benkovic, Ivana;
Zekan, Sime;
Begovac, Josip;
Cunha, Ana S.;
Teofilo, Eugenio;
Rodrigues, Goncalo;
Borges, Margarida D. F.;
Fatz, Duncan;
Vera, Jamie;
Whetham, Jennifer;
EmERGE Consortium

Publication type:

journal article

Comment on "An Integrated Pharmacokinetic–Pharmacodynamic–Pharmacoeconomic Modeling Method to Evaluate Treatments for Adults with Schizophrenia".

Published in:

PharmacoEconomics, 2022, v. 40, n. 12, p. 1261, doi. 10.1007/s40273-022-01200-3

By:

Rege, Bhaskar;
McGrory, James;
Gasper, Sabina;
McDonnell, David

Publication type:

Article

A Systematic Literature Review of the Economic Evaluations of Treatments for Patients with Chronic Myeloid Leukemia.

Published in:

PharmacoEconomics, 2022, v. 40, n. 12, p. 1159, doi. 10.1007/s40273-022-01189-9

By:

Agrawal, Rumjhum;
Vieira, Joao;
Ryan, Jacqueline;
Negi, Harish;
Rajput, Tanvi;
Corbin, Regina;
Viana, Ricardo

Publication type:

Article

Cost Effectiveness of the First‐in‐Class ARNI (Sacubitril/Valsartan) for the Treatment of Essential Hypertension in a Chinese Setting.

Published in:

PharmacoEconomics, 2022, v. 40, n. 12, p. 1187, doi. 10.1007/s40273-022-01182-2

By:

Dong, Xinyue;
He, Xiaoning;
Wu, Jing

Publication type:

Article

A Promising Approach to Optimizing Sequential Treatment Decisions for Depression: Markov Decision Process.

Published in:

2022

By:

Li, Fang;
Jörg, Frederike;
Li, Xinyu;
Feenstra, Talitha

Publication type:

journal article

Integrating the Biology of Cardiovascular Disease into the Epidemiology of Economic Decision Modelling via Mendelian Randomisation.

Published in:

2022

By:

Ademi, Zanfina;
Morton, Jedidiah I.;
Liew, Danny;
Nicholls, Stephen J.;
Zoungas, Sophia;
Ference, Brian A.

Publication type:

journal article

The Potential Value-Based Price of a Multi-Cancer Early Detection Genomic Blood Test to Complement Current Single Cancer Screening in the USA.

Published in:

2022

By:

Tafazzoli, Ali;
Ramsey, Scott D.;
Shaul, Alissa;
Chavan, Ameya;
Ye, Weicheng;
Kansal, Anuraag R.;
Ofman, Josh;
Fendrick, A. Mark

Publication type:

journal article

Engaging Patients and Caregivers in an Early Health Economic Evaluation: Discerning Treatment Value Based on Lived Experience.

Published in:

2022

By:

Wilson, Mackenzie;
Thavorn, Kednapa;
Hawrysh, Terry;
Graham, Ian D.;
Atkins, Harold;
Kekre, Natasha;
Coyle, Doug;
Lalu, Manoj M.;
Fergusson, Dean A.;
Chan, Kelvin K. W.;
Ollendorf, Daniel A.;
Presseau, Justin

Publication type:

journal article

Are We Agreed? Self- Versus Proxy-Reporting of Paediatric Health-Related Quality of Life (HRQoL) Using Generic Preference-Based Measures: A Systematic Review and Meta-Analysis.

Published in:

2022

By:

Khanna, Diana;
Khadka, Jyoti;
Mpundu-Kaambwa, Christine;
Lay, Kiri;
Russo, Remo;
Ratcliffe, Julie;
The Quality of Life in Kids: Key Evidence to Strengthen Decisions in Australia (QUOKKA) Project Team;
Devlin, Nancy;
Norman, Richard;
Viney, Rosalie;
Dalziel, Kim;
Mulhern, Brendan;
Hiscock, Harriet;
Street, Deborah;
Chen, Gang;
Peasgood, Tessa;
Bailey, Cate;
Yu, Alice;
Bahrampour, Mina;
Jones, Renee

Publication type:

meta analysis

A Proposal of a Cost-Effectiveness Modeling Approach for Heart Failure Treatment Assessment: Considering the Short- and Long-Term Impact of Hospitalization on Event Rates.

Published in:

2022

By:

Di Tanna, Gian Luca;
Angell, Blake;
Urbich, Michael;
Lindgren, Peter;
Gaziano, Thomas A.;
Globe, Gary;
Stollenwerk, Björn

Publication type:

journal article

Is EQ-5D-5L Better Than EQ-5D-3L Over Time? A Head-to-Head Comparison of Responsiveness of Descriptive Systems and Value Sets from Nine Countries.

Published in:

2022

By:

Janssen, Mathieu F.;
Buchholz, Ines;
Golicki, Dominik;
Bonsel, Gouke J.

Publication type:

journal article

Valuing the Quality-of-Life Aged Care Consumers (QOL-ACC) Instrument for Quality Assessment and Economic Evaluation.

Published in:

2022

By:

Ratcliffe, Julie;
Bourke, Siobhan;
Li, Jinhu;
Mulhern, Brendan;
Hutchinson, Claire;
Khadka, Jyoti;
Milte, Rachel;
Lancsar, Emily

Publication type:

journal article

Authors' Reply to Comment on "Cost-Effectiveness Analysis of Herpes Zoster Vaccination in 50- to 85-Year-Old Immunocompetent Belgian Cohorts: A Comparison Between No Vaccination, the Adjuvanted Subunit Vaccine, and Live-Attenuated Vaccine".

Published in:

PharmacoEconomics, 2022, v. 40, n. 10, p. 1013, doi. 10.1007/s40273-022-01186-y

By:

Bilcke, Joke;
Beutels, Philippe

Publication type:

Article

Comment on "Cost-Effectiveness Analysis of Herpes Zoster Vaccination in 50- to 85-Year-Old Immunocompetent Belgian Cohorts: A Comparison between No Vaccination, the Adjuvanted Subunit Vaccine, and Live-Attenuated Vaccine".

Published in:

PharmacoEconomics, 2022, v. 40, n. 10, p. 1011, doi. 10.1007/s40273-022-01184-0

By:

Giannelos, Nikolaos;
Nishimwe, Marie Libérée;
Lecrenier, Nicolas

Publication type:

Article

Developing an Online Infrastructure to Enhance Model Accessibility and Validation: The Peer Models Network.

Published in:

2022

By:

Harvard, Stephanie;
Adibi, Amin;
Easterbrook, Adam;
Werker, Gregory R.;
Murphy, David;
Grant, Don;
Mclean, Alison;
Majdzadeh, Zhina;
Sadatsafavi, Mohsen

Publication type:

Letter

Comment on "Cost Effectiveness of Vericiguat for the Treatment of Chronic Heart Failure with Reduced Ejection Fraction Following a Worsening Heart Failure Event from a US Medicare Perspective".

Published in:

2022

By:

Gandjour, Afschin

Publication type:

Letter

Authors' Reply to Comment on "Risk-Adjusted Performance Measures".

Published in:

PharmacoEconomics, 2022, v. 40, n. 7, p. 741, doi. 10.1007/s40273-022-01154-6

By:

Elbasha, Elamin H.

Publication type:

Article

Current Practices for Accounting for Preference Heterogeneity in Health-Related Discrete Choice Experiments: A Systematic Review.

Published in:

2022

By:

Karim, Suzana;
Craig, Benjamin M.;
Vass, Caroline;
Groothuis-Oudshoorn, Catharina G. M.

Publication type:

journal article

A Comparison of the Content and Consistency of Methodological Quality and Transferability Checklists for Reviewing Model-Based Economic Evaluations.

Published in:

2022

By:

Lim, Ka Keat;
Koleva-Kolarova, Rositsa;
Fox-Rushby, Julia

Publication type:

journal article

Budget Impact Analysis of Vibegron for the Treatment of Overactive Bladder in the USA.

Published in:

2022

By:

Chen, Jing Voon;
Gahn, James C.;
Nesheim, Jeffrey;
Mudd Jr., Paul N.;
Mudd, Paul N Jr

Publication type:

journal article

China Health Related Outcomes Measures (CHROME): Development of a New Generic Preference-Based Measure for the Chinese Population.

Published in:

2022

By:

Wu, Jing;
He, Xiaoning;
Chen, Pinan;
Xie, Shitong;
Li, Xue;
Hu, Hao;
Zhao, Kun;
Xie, Feng;
CHROME Study Group

Publication type:

journal article

Tools for the Economic Evaluation of Precision Medicine: A Scoping Review of Frameworks for Valuing Heterogeneity-Informed Decisions.

Published in:

2022

By:

Pataky, Reka E.;
Bryan, Stirling;
Sadatsafavi, Mohsen;
Peacock, Stuart;
Regier, Dean A.

Publication type:

journal article

Collaborating with Patient Partners to Model Clinical Care Pathways in Major Depressive Disorder: The Benefits of Mixing Evidence and Lived Experience.

Published in:

2022

By:

Bunka, Mary;
Ghanbarian, Shahzad;
Riches, Linda;
Landry, Ginny;
Edwards, Louisa;
Hoens, Alison M.;
Bryan, Stirling

Publication type:

journal article

The Cost Effectiveness of Axicabtagene Ciloleucel Versus Best Supportive Care in the Treatment of Adult Patients with Relapsed or Refractory Large B-Cell Lymphoma (LBCL) After Two or More Lines of Systemic Therapy in Canada.

Published in:

2022

By:

Hillis, Christopher;
Vicente, Colin;
Ball, Graeme

Publication type:

journal article

Belimumab for Treating Active Autoantibody-Positive Systemic Lupus Erythematosus: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Published in:

2022

By:

Otten, Thomas;
Riemsma, Rob;
Wijnen, Ben;
Armstrong, Nigel;
Stirk, Lisa;
Gordon, Caroline;
Ramaekers, Bram;
Kleijnen, Jos;
Joore, Manuela;
Grimm, Sabine

Publication type:

journal article

Carers' Health-Related Quality of Life in Global Health Technology Assessment: Guidance, Case Studies and Recommendations.

Published in:

2022

By:

Pennington, Becky;
Eaton, Jack;
Hatswell, Anthony J;
Taylor, Helen

Publication type:

journal article

Cost-Effectiveness, Burden of Disease and Budget Impact of Inclisiran: Dynamic Cohort Modelling of a Real-World Population with Cardiovascular Disease.

Published in:

PharmacoEconomics, 2022, v. 40, n. 8, p. 791, doi. 10.1007/s40273-022-01152-8

By:

Galactionova, Katya;
Salari, Paola;
Mattli, Renato;
Rachamin, Yael;
Meier, Rahel;
Schwenkglenks, Matthias

Publication type:

Article

Risk-Adjusted Performance Measures: A Comment on Elbasha.

Published in:

PharmacoEconomics, 2022, v. 40, n. 7, p. 739, doi. 10.1007/s40273-022-01153-7

By:

Sendi, Pedram;
Schwenkglenks, Matthias

Publication type:

Article

Best-Worst Scaling and the Prioritization of Objects in Health: A Systematic Review.

Published in:

2022

By:

Hollin, Ilene L.;
Paskett, Jonathan;
Schuster, Anne L. R.;
Crossnohere, Norah L.;
Bridges, John F. P.

Publication type:

research

Does the Structure Matter? An External Validation and Health Economic Results Comparison of Event Simulation Approaches in Severe Obesity.

Published in:

2022

By:

Schwander, Björn;
Kaier, Klaus;
Hiligsmann, Mickaël;
Evers, Silvia;
Nuijten, Mark

Publication type:

journal article

Cost-Effectiveness Analysis of Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography (PET/CT) for the Primary Staging of Prostate Cancer in Australia.

Published in:

PharmacoEconomics, 2022, v. 40, n. 8, p. 807, doi. 10.1007/s40273-022-01156-4

By:

Song, Rachel;
Jeet, Varinder;
Sharma, Rajan;
Hoyle, Martin;
Parkinson, Bonny

Publication type:

Article

A Framework for Integrating Continuous Glucose Monitor-Derived Metrics into Economic Evaluations in Type 1 Diabetes.

Published in:

PharmacoEconomics, 2022, v. 40, n. 8, p. 743, doi. 10.1007/s40273-022-01148-4

By:

Benedict, Ágnes;
Hankosky, Emily R.;
Marczell, Kinga;
Chen, Jieling;
Klein, David J.;
Caro, J. Jaime;
Bae, Jay P.;
Benneyworth, Brian D.

Publication type:

Article